Functional genomics of PPAR-γ in human immunomodulatory cells

Molecular and Cellular Biochemistry

Volumn 290, Issue 1-2, 2006, Pages 211-215

  Kaul, Deepak ^a   Anand, Paras K ^a   Khanna, Amit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Effect orgenes; Gene; Innate immunity; PPAR ; SiRNA

Indexed keywords

CD36 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CELL CULTURE; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOMODULATION; INCUBATION TIME; INFLAMMATION; INNATE IMMUNITY; LIPID METABOLISM; MONONUCLEAR CELL; NORMAL HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

CELLS, CULTURED; GENOMICS; HUMANS; IMMUNITY, INNATE; IMMUNITY, NATURAL; INFLAMMATION; LIPID METABOLISM; PPAR GAMMA; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33749176815     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9169-8     Document Type: Article

References (24)

1. Laman JD, Bart JGL, Schoneveld A, van Meurs M: CD40-CD40L interactions in atherosclerosis. Immunol Today 18: 272-277, 1997
2. Kutuk O, Bagasa H: Inflammation meets oxidation: NF-kB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 9: 549-557, 2003
3. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM: A PPARg-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7: 161-171, 2001
4. Chung SW, Kang BY, Kim TS: Inhibition of IL-4 production in CD4+ T-cells by Peroxisome-proliferators activated receptor-γ (PPAR-γ) ligands: Involvement of physical association between PPAR-gamma and the nuclear factor of activated T-cells transcription factor. Mol Pharmacol 64: 1169-1179, 2003
5. Duval C, Chinetti G, Trottein F, Fruchar JC, Stael B: The role of PPARs in atherosclerosis. Trends Mol Med 8: 422-430, 2002
6. Hsueh WA, Bruemmer D: Peroxisome-proliferators activated receptors-gamma: Implications for cardiovascular disease. Hypertension 43: 297, 2004
7. Varma N, Varma S, Kaul D: Expression of Receptor-Ck and SREBP genes in mononuclear cells from acute leukemic patients. Leuk Res 24: 913-916, 2000
8. Chomczynski P, Sacchi N: Single step method for RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162: 156-159, 1987
9. Kaul D, Sikand K, Shukla AR: Effect of green tea polyphenols on the genes with atherosclerotic potential. Phytother Res 18: 177-179, 2004
10. Glare EM, Divjak M, Bailey MJ, Walters EH: The usefulness of competitive PCR: Airway gene expression of IL-5, IL-4, IL-4d2 and IFN-gamma in asthma. Thorax 26: 541-548, 2001
11. Barlic J, Sechler JM, Murphy PM: IL-15 and IL-12 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 102: 3494-3503, 2003
12. Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemera M, Kawase I, Tanaka T: Fistein, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J Allergy Clin Immunol 111: 1299-1306, 2003
13. Kaul D, Sikand K: Defective RNA-mediated c-myc gene silencing pathway in burkitt's lymphoma. Biochem Biophy Res Commun 313: 562-564, 2004
14. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997
15. Kaul D, Anand PK: Regulation of PPAR-gamma gene in human promyelocytic HL-60 cell line. Leuk Res 27: 683-686, 2003
16. Desvergne B, Wahli W: Peroxisome-proliferators activated receptors: Nuclear control of metabolism. Endocrine Rev 20: 649, 1999
17. Kaul D: Cholesterol-receptor-mediated genomics in health and disease. Trends Mol Med 9: 442-449, 2003
18. Valledor AF: The innate immune response under the control of LXR pathway. Immunobiol 210: 127-132, 2005
19. Sikand K, Kaul D: A novel genetic aberration in burkitt's lymphoma. Int J Cancer Prevention in press, 2005
20. Ricote M, Valledor AF, Glass CK: Decoding transcriptional programs regulated by PPARs and LXRs in the macropahge. Arteriosclerosis, Thrombosis and Vascul Biol 24: 230, 2004
21. Moatti D, Faure S, Fumeron F, Armara MEW, Seknadji P, McDermott DH, Debre P, Aurront MC, Murphy PM, deProst D, Combadiere C: Polymorphism in the fractalkine receptor-CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97: 1925, 2001
22. Bream JH, Curiel RE, Yu CR, Egwuagu CE, Grusby MJ, Aune TM, Young HA: IL-4 synergistically enhances both IL-2 and IL-12 induced IFN-g expression in murine NK-cells. Blood 102: 207-214, 2003
23. Feng J, Han J, Pearce SF, Silverstein RL, Gotto Jr. AM, Hajjar DP, Nicholson AC: Induction of CD36 expression by oxidized-LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. Lipid Res 41: 688-696, 2000
24. Bortel DP: MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004